Abstract:Topoisomerase 1 (top1) inhibitors are proving useful against a range of refractory tumors, and there is considerable interest in the development of additional top1 agents. Despite crystallographic studies, the binding site and ligand properties that lead to activity are poorly understood. Here we report a unique approach to quantitative structure-activity relationship (QSAR) analysis based on the National Cancer Institute's (NCI) drug databases. In 1990, the NCI established a drug discovery program in which compounds are tested for their ability to inhibit the growth of 60 different human cancer cell lines in culture. More than 70 000 compounds have been screened, and patterns of activity against the 60 cell lines have been found to encode rich information on mechanisms of drug action and drug resistance. Here, we use hierarchical clustering to define antitumor activity patterns in a data set of 167 tested camptothecins (CPTs) in the NCI drug database. The average pairwise Pearson correlation coefficient between activity patterns for the CPT set was 0.70. Coherence between chemical structures and their activity patterns was observed. QSAR studies were carried out using the mean 50% growth inhibitory concentrations (GI(50)) for 60 cell lines as the dependent variables. Different statistical methods, including stepwise linear regression, principal component regression (PCR), partial least-squares regression (PLS), and fully cross-validated genetic function approximation (GFA) were applied to construct quantitative structure-antitumor relationship models. For our data set, the GFA method performed better in terms of correlation coefficients and cross-validation analysis. A number of molecular descriptors were identified as being correlated with antitumor activity. Included were partial atomic charges and three interatomic distances that define the relative spatial dispositions of three significant atoms (the hydroxyl hydrogen of the E-ring, the lactone carbonyl oxygen of the E-ring, and the carbonyl oxygen of the D-ring). The cross-validated r(2) for the final GFA model was 0.783, indicating a predictive QSAR model.

The QSAR research of paclitaxel analogues

The QSAR Research of Taxoids Compounds

Study on the Quantitative Structure-Activity Relationships of 10-Oac -Paclitaxel Analogues

QSAR Research of Novel Tetrandrine Derivatives Against Human Hepatocellular Carcinoma.

Research Advances in Clinical Applications, Anticancer Mechanism, Total Chemical Synthesis, Semi-Synthesis and Biosynthesis of Paclitaxel

Molecular-docking-guided design, palladium-catalyzed synthesis and anticancer activity of paclitaxel-benzoxazoles hybrids

[Analysis of Paclitaxel Concentration in Rat Plasma by Raman Spectrums Combined with Partial Least Square].

Quantification of paclitaxel in rat plasma by LC-MS/MS and pharmacokinetics of paclitaxel thermosensi-tive liposomes in rats

Quantitative Structure-Antitumor Activity Relationships Of Camptothecin Analogues: Cluster Analysis And Genetic Algorithm-Based Studies

[Advances in paclitaxel biosynthesis and transcriptional regulation mechanisms]

Computational QSAR Models with High-Dimensional Descriptor Selection Improve Antitumor Activity Design of ARC-111 Analogues

Progress on the Prodrugs of Paclitaxel

Unveiling the Therapeutic Potential of Paclitaxel Combinations Against Breast Carcinoma and Identification of In Vivo Biomarkers

Research Progress in the Quantitative Structure-Antitumor Activity Relationship Studies of Taxol Derivatives

Biosynthesis of paclitaxel using synthetic biology

Synthesis of Paclitaxel Derivatives for Remote Loading into Liposomes and Improved Therapeutic Effect

Model-Based Meta-Analysis of Population Pharmacokinetic Models for Paclitaxel in Humans,Rats and Mice

Synthesis of Paclitaxel Side Chain Via Multi-Component Reaction and Its Application to the Synthesis of Paclitaxel Analogues

Near Infrared Spectroscopic Combined with Partial Least Squares and Radial Basis Function Neural Network to Analyze Paclitaxel Concentration in Rat Plasma

Anti-breast Cancer Drug Design and ADMET Prediction of ERa Antagonists Based on QSAR Study

Novel progressive deep learning algorithm for uncovering multiple single nucleotide polymorphism interactions to predict paclitaxel clearance in patients with nonsmall cell lung cancer